Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,048.81
1,003.33
971.73
1,249.55
1,087.40
947.19
1,162.61
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,048.81
1,003.33
971.73
1,249.55
1,087.40
947.19
1,162.61
Raw Material Cost
684.96
694.42
750.06
884.89
743.73
656.55
800.19
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
25.85
19.16
12.17
26.72
24.56
24.38
5.35
Selling and Distribution Expenses
194.05
184.58
196.40
202.78
195.55
185.15
233.70
Other Expenses
0.52
0.80
3.01
0.85
0.55
0.17
1.92
Total Expenditure (Excl Depreciation)
910.07
906.14
988.75
1,122.88
969.36
867.82
1,058.44
Operating Profit (PBDIT) excl Other Income
138.7
97.2
-17
126.7
118
79.4
104.2
Other Income
14.14
-18.65
-23.00
13.56
4.66
7.64
13.85
Operating Profit (PBDIT)
212.91
143.59
-234.14
207.19
177.02
156.25
180.78
Interest
25.85
19.16
12.17
26.72
24.56
24.38
5.35
Exceptional Items
-1.15
-1.03
59.55
0.00
-0.20
1.56
-26.24
Gross Profit (PBDT)
363.85
308.90
221.67
364.67
343.67
290.65
362.42
Depreciation
71.62
71.62
74.07
74.07
68.57
68.57
74.48
Profit Before Tax
114.28
51.78
-260.84
106.40
83.69
64.86
74.70
Tax
13.79
9.86
-59.41
20.83
3.92
8.37
5.41
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
103.02
49.91
-123.74
99.15
92.48
68.64
85.26
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
103.02
49.91
-123.74
99.15
92.48
68.64
85.26
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.52
-7.98
-77.70
-13.58
-12.70
-12.15
-15.97
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
100.49
41.93
-201.43
85.57
79.77
56.49
69.29
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
0.0
1.0
Reserves
3,046.96
2,957.91
2,942.33
2,654.06
2,553.76
2,591.18
2,505.83
Earnings per share (EPS)
0.33
0.16
-0.4
0.32
0.3
0.22
0.28
Diluted Earnings per share
0.33
0.16
-0.4
0.32
0.3
0.22
0.28
Operating Profit Margin (Excl OI)
12.12%
9.03%
-29.35%
9.57%
9.54%
8.45%
7.95%
Gross Profit Margin
17.73%
12.3%
-19.22%
14.44%
14.0%
14.09%
12.83%
PAT Margin
9.82%
4.97%
-12.73%
7.93%
8.5%
7.25%
7.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -3.55% vs 4.66% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 25.94% vs -2.68% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 15.31% vs -7.01% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 5.28% vs -12.77% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Sirio Pharma Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,048.81
0
1,048.81
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,048.81
0
1,048.81
Raw Material Cost
684.96
0
684.96
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
25.85
0
25.85
Selling and Distribution Expenses
194.05
0
194.05
Other Expenses
0.52
0.00
0.52
Total Expenditure (Excl Depreciation)
910.07
0
910.07
Operating Profit (PBDIT) excl Other Income
138.74
0.00
138.74
Other Income
14.14
0
14.14
Operating Profit (PBDIT)
212.91
0
212.91
Interest
25.85
0
25.85
Exceptional Items
-1.15
0
-1.15
Gross Profit (PBDT)
363.85
0
363.85
Depreciation
71.62
0
71.62
Profit Before Tax
114.28
0
114.28
Tax
13.79
0
13.79
Provisions and contingencies
0
0
0.00
Profit After Tax
103.02
0
103.02
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
103.02
0
103.02
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.52
0
-2.52
Other related items
0.00
0.00
0.00
Consolidated Net Profit
100.49
0
100.49
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,046.96
0
3,046.96
Earnings per share (EPS)
0.33
0
0.33
Diluted Earnings per share
0.33
0
0.33
Operating Profit Margin (Excl OI)
12.12%
0%
0.00
12.12%
Gross Profit Margin
17.73%
0%
0.00
17.73%
PAT Margin
9.82%
0%
0.00
9.82%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 104.88 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 4.54% vs 3.25% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -3.55% vs 4.66% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 10.05 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 139.86% vs 120.80% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 25.94% vs -2.68% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.88 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 22.56% vs 176.84% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 15.31% vs -7.01% in Jun 2025
Quarterly - Interest
Interest 2.59 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 34.90% vs 57.38% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 5.28% vs -12.77% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.12%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
